India Ratings assigns Jubilant Ingrevia 'IND AA' rating

Image
Capital Market
Last Updated : Jun 05 2021 | 4:16 PM IST

Credit ratings agency India Ratings and Research (Ind-Ra) assigned Jubilant Ingrevia (JVL) a long-term issuer rating of 'IND AA' with a stable outlook.

The ratings agency assigned a credit rating of 'IND AA/Stable/IND A1+' on the company's fund-based limits of Rs 475 crore. It has assigned 'IND A1+' rating on the non-fund-based limits of the company worth Rs 772.5 crore.

India Ratings and Research said that it has taken a consolidated view of JVL and its wholly-owned subsidiaries Jubilant Infrastructure ('IND A-'/Stable), Jubilant Lifesciences International, Jubilant Lifesciences NV, Jubilant Lifesciences USA Inc. and Jubilant Lifesciences Shanghai to arrive at the ratings, given the strong operational and strategic ties among them.

Effective 1 February 2021, the life science ingredients (LSI) business of Jubilant Life Sciences was demerged to JVL. The demerger was carried out to create separate and focused entities for the pharma and LSI businesses to unlock shareholder value and generate greater operational efficiencies, along with a dedicated management structure. JVL's business comprises specialty chemicals (SC; 34% of 9MFY21 sales;), nutrition and Health solutions (NP; 18%;) and life science chemicals (LSC; 48%;) businesses.

JVL has presence across three segments in SC, nutrition and health solutions and LSC, with healthy levels of backward integration and a leading market position. The ratings factor in the healthy balance sheet post business carve out of pharma business with JVL holding only long-term debt, which is not significant.

JVL is an integrated life science products company and provides innovative solutions to pharmaceutical, nutrition, agrochemical, consumer and industrial customers. The company's portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. The company has five manufacturing facilities located in Gujarat, Maharashtra and Uttar Pradesh.

The scrip jumped 9.51% to end at Rs 571.85 on Friday.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 05 2021 | 3:47 PM IST

Next Story